A Phase 1 Crossover Study of Blood Pressure and Heart Rate Response to Pseudoephedrine Concurrent With Placebo or TR 701 FA.

Trial Profile

A Phase 1 Crossover Study of Blood Pressure and Heart Rate Response to Pseudoephedrine Concurrent With Placebo or TR 701 FA.

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Oct 2017

At a glance

  • Drugs Tedizolid (Primary) ; Pseudoephedrine
  • Indications Bacteraemia; Bacterial infections; Gram-positive infections; Skin and soft tissue infections
  • Focus Pharmacodynamics
  • Sponsors Trius Therapeutics
  • Most Recent Events

    • 12 Jun 2013 Results were published in Antimicrobial Agents and Chemotherapy, according to a Trius Therapeutics media release.
    • 29 Apr 2013 Results presented at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) meeting, according to a Trius Therapeutics media release.
    • 11 Sep 2012 Results will be presented at ICAAC-2012 according to a Trius Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top